BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 1260766)

  • 1. Inhibition of tubulin-microtubule polymerization by drugs of the Vinca alkaloid class.
    Owellen RJ; Hartke CA; Dickerson RM; Hains FO
    Cancer Res; 1976 Apr; 36(4):1499-502. PubMed ID: 1260766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on microtubules in vitro.
    Himes RH; Kersey RN; Heller-Bettinger I; Samson FE
    Cancer Res; 1976 Oct; 36(10):3798-802. PubMed ID: 954003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of vinca alkaloids with tubulin: a comparison of vinblastine, vincristine, and vinorelbine.
    Lobert S; Vulevic B; Correia JJ
    Biochemistry; 1996 May; 35(21):6806-14. PubMed ID: 8639632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vinblastine inhibition of microtubule assembly in vitro.
    Sajó I
    Acta Biochim Biophys Acad Sci Hung; 1977; 12(3):259-61. PubMed ID: 602674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro inhibition of microtubule assembly by disulfiram.
    Potchoo Y; Braguer D; Peyrot V; Chauvet-Monges AM; Sari JC; Crevat A
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):499-504. PubMed ID: 3781685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microtubules as drug receptors: pharmacological properties of microtubule protein.
    Wilson L
    Ann N Y Acad Sci; 1975 Jun; 253():213-31. PubMed ID: 1096718
    [No Abstract]   [Full Text] [Related]  

  • 7. Action of drugs on microtubules.
    Wilson L
    Life Sci; 1975 Aug; 17(3):303-9. PubMed ID: 1099380
    [No Abstract]   [Full Text] [Related]  

  • 8. Tubulin-targeted drug action: functional significance of class ii and class IVb beta-tubulin in vinca alkaloid sensitivity.
    Gan PP; Kavallaris M
    Cancer Res; 2008 Dec; 68(23):9817-24. PubMed ID: 19047161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Block of axoplasmic transport in vitro by vinca alkaloids.
    Chan SY; Worth R; Ochs S
    J Neurobiol; 1980 May; 11(3):251-64. PubMed ID: 6156229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Energetics of vinca alkaloid interactions with tubulin isotypes: implications for drug efficacy and toxicity.
    Lobert S; Frankfurter A; Correia JJ
    Cell Motil Cytoskeleton; 1998; 39(2):107-21. PubMed ID: 9484953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of dolastatin 10 to tubulin at a distinct site for peptide antimitotic agents near the exchangeable nucleotide and vinca alkaloid sites.
    Bai RL; Pettit GR; Hamel E
    J Biol Chem; 1990 Oct; 265(28):17141-9. PubMed ID: 2211617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calmodulin, activated cyclic nucleotide phosphodiesterase, microtubules, and vinca alkaloids.
    Watanabe K; West WL
    Fed Proc; 1982 May; 41(7):2292-9. PubMed ID: 6122611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of the net exchange rate of tubulin dimer in steady-state microtubules by fluorescence correlation spectroscopy.
    Neumann T; Kirschstein SO; Camacho Gomez JA; Kittler L; Unger E
    Biol Chem; 2001 Mar; 382(3):387-91. PubMed ID: 11347885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additivity of dilantin and vinblastine inhibitory effects on microtubule assembly.
    Lobert S; Ingram JW; Correia JJ
    Cancer Res; 1999 Oct; 59(19):4816-22. PubMed ID: 10519390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydantoin drugs inhibit polymerization of pure microtubular protein.
    MacKinney AA; Vyas RS; Walker D
    J Pharmacol Exp Ther; 1978 Jan; 204(1):189-94. PubMed ID: 619129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divalent cation and ionic strength effects on Vinca alkaloid-induced tubulin self-association.
    Lobert S; Boyd CA; Correia JJ
    Biophys J; 1997 Jan; 72(1):416-27. PubMed ID: 8994628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective and reversible effects of vinca alkaloids on Trypanosoma cruzi epimastigote forms: blockage of cytokinesis without inhibition of the organelle duplication.
    Grellier P; Sinou V; Garreau-de Loubresse N; Bylèn E; Boulard Y; Schrével J
    Cell Motil Cytoskeleton; 1999; 42(1):36-47. PubMed ID: 9915583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin.
    Gupta K; Bishop J; Peck A; Brown J; Wilson L; Panda D
    Biochemistry; 2004 Jun; 43(21):6645-55. PubMed ID: 15157098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular docking and pharmacogenomics of vinca alkaloids and their monomeric precursors, vindoline and catharanthine.
    Sertel S; Fu Y; Zu Y; Rebacz B; Konkimalla B; Plinkert PK; Krämer A; Gertsch J; Efferth T
    Biochem Pharmacol; 2011 Mar; 81(6):723-35. PubMed ID: 21219884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic selectivity of vinca alkaloids: a role for guanosine 5'-triphosphate?
    Houghton PJ; Houghton JA; Bowman LC; Hazelton BJ
    Anticancer Drug Des; 1987 Oct; 2(2):165-79. PubMed ID: 3329524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.